Antisense Therapeutics Financials
| ATHJF Stock | USD 0.04 0.00 0.00% |
Antisense |
Understanding current and past Antisense Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Antisense Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Antisense Therapeutics' assets may result in an increase in income on the income statement.
Antisense Therapeutics Stock Summary
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 14 Wallace Avenue, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.antisense.com.au |
| Phone | 61 3 9827 8999 |
| Currency | USD - US Dollar |
Antisense Therapeutics Key Financial Ratios
There are many critical financial ratios that Antisense Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Antisense Therapeutics reports annually and quarterly.Antisense Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Antisense Therapeutics's current stock value. Our valuation model uses many indicators to compare Antisense Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Antisense Therapeutics competition to find correlations between indicators driving Antisense Therapeutics's intrinsic value. More Info.Antisense Therapeutics Limited is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Antisense Therapeutics' earnings, one of the primary drivers of an investment's value.Antisense Therapeutics Systematic Risk
Antisense Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Antisense Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Antisense Therapeutics correlated with the market. If Beta is less than 0 Antisense Therapeutics generally moves in the opposite direction as compared to the market. If Antisense Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Antisense Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Antisense Therapeutics is generally in the same direction as the market. If Beta > 1 Antisense Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Antisense Therapeutics November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Antisense Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Antisense Therapeutics Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Antisense Therapeutics Limited based on widely used predictive technical indicators. In general, we focus on analyzing Antisense Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Antisense Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1138 | |||
| Maximum Drawdown | 330.62 |
Complementary Tools for Antisense Pink Sheet analysis
When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |